1
|
Beyls C, Martin N, Booz T, Viart C, Boisgard S, Daumin C, Crombet M, Epailly J, Huette P, Dupont H, Abou-Arab O, Mahjoub Y. Prognostic value of acute cor pulmonale in COVID-19-related pneumonia: A prospective study. Front Med (Lausanne) 2022; 9:824994. [PMID: 36267616 PMCID: PMC9576859 DOI: 10.3389/fmed.2022.824994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Accepted: 09/05/2022] [Indexed: 12/01/2022] Open
Abstract
Background It is known that acute cor pulmonale (ACP) worsens the prognosis of non-coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (NC-ARDS). The ACP risk score evaluates the risk of ACP occurrence in mechanically ventilated patients with NC-ARDS. There is less data on the risk factors and prognosis of ACP induced by COVID-19-related pneumonia. Objective The objective of this study was to evaluate the prognostic value of ACP, assessed by transthoracic echocardiography (TTE) and clinical factors associated with ACP in a cohort of patients with COVID-19-related pneumonia. Materials and methods Between February 2020 and June 2021, patients admitted to intensive care unit (ICU) at Amiens University Hospital for COVID-19-related pneumonia were assessed by TTE within 48 h of admission. ACP was defined as a right ventricle/left ventricle area ratio of >0.6 associated with septal dyskinesia. The primary outcome was mortality at 30 days. Results Among 146 patients included, 36% (n = 52/156) developed ACP of which 38% (n = 20/52) were non-intubated patients. The classical risk factors of ACP (found in NC-ARDS) such as PaCO2 >48 mmHg, driving pressure >18 mmHg, and PaO2/FiO2 < 150 mmHg were not associated with ACP (all P-values > 0.1). The primary outcome occurred in 32 (22%) patients. More patients died in the ACP group (n = 20/52 (38%) vs. n = 12/94 (13%), P = 0.001). ACP [hazards ratio (HR) = 3.35, 95%CI [1.56–7.18], P = 0.002] and age >65 years (HR = 2.92, 95%CI [1.50–5.66], P = 0.002) were independent risk factors of 30-day mortality. Conclusion ACP was a frequent complication in ICU patients admitted for COVID-19-related pneumonia. The 30-day-mortality was 38% in these patients. In COVID-19-related pneumonia, the classical risk factors of ACP did not seem relevant. These results need confirmation in further studies.
Collapse
Affiliation(s)
- Christophe Beyls
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France,UR UPJV 7518 SSPC (Simplification of Care of Complex Surgical Patients) Research Unit, Jules Verne University of Picardie, Amiens, France,*Correspondence: Christophe Beyls,
| | - Nicolas Martin
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France
| | - Thomas Booz
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France
| | - Christophe Viart
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France
| | - Solenne Boisgard
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France
| | - Camille Daumin
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France
| | - Maxime Crombet
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France
| | - Julien Epailly
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France
| | - Pierre Huette
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France,UR UPJV 7518 SSPC (Simplification of Care of Complex Surgical Patients) Research Unit, Jules Verne University of Picardie, Amiens, France
| | - Hervé Dupont
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France,UR UPJV 7518 SSPC (Simplification of Care of Complex Surgical Patients) Research Unit, Jules Verne University of Picardie, Amiens, France
| | - Osama Abou-Arab
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France
| | - Yazine Mahjoub
- Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France,UR UPJV 7518 SSPC (Simplification of Care of Complex Surgical Patients) Research Unit, Jules Verne University of Picardie, Amiens, France
| |
Collapse
|
2
|
Statsenko Y, Habuza T, Talako T, Pazniak M, Likhorad E, Pazniak A, Beliakouski P, Gelovani JG, Gorkom KNV, Almansoori TM, Al Zahmi F, Qandil DS, Zaki N, Elyassami S, Ponomareva A, Loney T, Naidoo N, Mannaerts GHH, Al Koteesh J, Ljubisavljevic MR, Das KM. Deep Learning-Based Automatic Assessment of Lung Impairment in COVID-19 Pneumonia: Predicting Markers of Hypoxia With Computer Vision. Front Med (Lausanne) 2022; 9:882190. [PMID: 35957860 PMCID: PMC9360571 DOI: 10.3389/fmed.2022.882190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Accepted: 06/14/2022] [Indexed: 01/19/2023] Open
Abstract
Background Hypoxia is a potentially life-threatening condition that can be seen in pneumonia patients. Objective We aimed to develop and test an automatic assessment of lung impairment in COVID-19 associated pneumonia with machine learning regression models that predict markers of respiratory and cardiovascular functioning from radiograms and lung CT. Materials and Methods We enrolled a total of 605 COVID-19 cases admitted to Al Ain Hospital from 24 February to 1 July 2020 into the study. The inclusion criteria were as follows: age ≥ 18 years; inpatient admission; PCR positive for SARS-CoV-2; lung CT available at PACS. We designed a CNN-based regression model to predict systemic oxygenation markers from lung CT and 2D diagnostic images of the chest. The 2D images generated by averaging CT scans were analogous to the frontal and lateral view radiograms. The functional (heart and breath rate, blood pressure) and biochemical findings (SpO2, HCO3-, K+, Na+, anion gap, C-reactive protein) served as ground truth. Results Radiologic findings in the lungs of COVID-19 patients provide reliable assessments of functional status with clinical utility. If fed to ML models, the sagittal view radiograms reflect dyspnea more accurately than the coronal view radiograms due to the smaller size and the lower model complexity. Mean absolute error of the models trained on single-projection radiograms was approximately 11÷12% and it dropped by 0.5÷1% if both projections were used (11.97 ± 9.23 vs. 11.43 ± 7.51%; p = 0.70). Thus, the ML regression models based on 2D images acquired in multiple planes had slightly better performance. The data blending approach was as efficient as the voting regression technique: 10.90 ± 6.72 vs. 11.96 ± 8.30%, p = 0.94. The models trained on 3D images were more accurate than those on 2D: 8.27 ± 4.13 and 11.75 ± 8.26%, p = 0.14 before lung extraction; 10.66 ± 5.83 and 7.94 ± 4.13%, p = 0.18 after the extraction. The lung extraction boosts 3D model performance unsubstantially (from 8.27 ± 4.13 to 7.94 ± 4.13%; p = 0.82). However, none of the differences between 3D and 2D were statistically significant. Conclusion The constructed ML algorithms can serve as models of structure-function association and pathophysiologic changes in COVID-19. The algorithms can improve risk evaluation and disease management especially after oxygen therapy that changes functional findings. Thus, the structural assessment of acute lung injury speaks of disease severity.
Collapse
Affiliation(s)
- Yauhen Statsenko
- Department of Radiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
- Abu Dhabi Precision Medicine Virtual Research Institute (AD PM VRI), United Arab Emirates University, Al Ain, United Arab Emirates
- *Correspondence: Yauhen Statsenko
| | - Tetiana Habuza
- Department of Computer Science and Software Engineering, College of Information Technology, United Arab Emirates University, Al Ain, United Arab Emirates
- Big Data Analytics Center, United Arab Emirates University, Al Ain, United Arab Emirates
- Tetiana Habuza
| | - Tatsiana Talako
- Department of Radiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | | | - Elena Likhorad
- Department of Radiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
- Eye Microsurgery Center “Voka”, Minsk, Belarus
- Elena Likhorad
| | | | | | - Juri G. Gelovani
- Biomedical Engineering Department, College of Engineering, Wayne State University, Detroit, MI, United States
- Siriraj Hospital, Mahidol University, Nakhon Pathom, Thailand
| | - Klaus Neidl-Van Gorkom
- Department of Radiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | - Taleb M. Almansoori
- Department of Radiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | - Fatmah Al Zahmi
- Department of Neurology, Mediclinic Parkview Hospital, Dubai, United Arab Emirates
- Department of Clinical Science, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates
| | - Dana Sharif Qandil
- College of Medical Sciences, Ras Al Khaimah Medical Health and Sciences University, Ras Al Khaimah, United Arab Emirates
| | - Nazar Zaki
- Abu Dhabi Precision Medicine Virtual Research Institute (AD PM VRI), United Arab Emirates University, Al Ain, United Arab Emirates
- Department of Computer Science and Software Engineering, College of Information Technology, United Arab Emirates University, Al Ain, United Arab Emirates
| | - Sanaa Elyassami
- Department of Computer Science, Abu Dhabi Polytechnic, Abu Dhabi, United Arab Emirates
| | - Anna Ponomareva
- Scientific-Research Institute of Medicine and Dentistry, Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - Tom Loney
- Department of Public Health and Epidemiology, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates
| | - Nerissa Naidoo
- Department of Anatomy, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates
| | - Guido Hein Huib Mannaerts
- Department of Surgery, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
- Department of Surgery, Tawam Hospital, Abu Dhabi, United Arab Emirates
| | - Jamal Al Koteesh
- Department of Radiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
- Department of Radiology, Tawam Hospital, Abu Dhabi, United Arab Emirates
- Jamal Al Koteesh
| | - Milos R. Ljubisavljevic
- Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| | - Karuna M. Das
- Department of Radiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
| |
Collapse
|
3
|
Schaarschmidt BM, Fistera D, Li Y, Konik M, Haubold J, Grueneisen J, Witzke O, Forsting M, Holzner C, Umutlu L. Streamlining Patient Management of Suspected COVID-19 Patients in the Emergency Department: Incorporation of Pulmonary CT Angiography into the Triaging Algorithm. Diagnostics (Basel) 2022; 12:diagnostics12051183. [PMID: 35626338 PMCID: PMC9140044 DOI: 10.3390/diagnostics12051183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Revised: 04/26/2022] [Accepted: 05/06/2022] [Indexed: 11/23/2022] Open
Abstract
Purpose: To evaluate the use of pulmonary computed tomography (CT) angiography during initial admission at an emergency department (ED), to identify COVID-19 patients with accompanying pulmonary embolism (PE) and its impact on clinical management. Methods: We performed a retrospective analysis of COVID-19 patients that underwent pulmonary CT angiography at the ED. CT scans were evaluated for the presence and extent of PE and for imaging changes suspicious of COVID-19. Patients were subdivided into two groups: (1) Group A consisted of patients with proven COVID-19 based on real-time polymerase chain reaction (RT-PCR), and (2) Group B of patients suspected for COVID-19, comprising patients positive on RT-PCR and/or COVID-19-suspicious CT findings. To assess the differences between patients with and without pulmonary embolism, Fisher’s exact test was used. Results: A total of 308 patients were admitted to the ED for diagnostic work-up of dyspnea and suspected COVID-19, and 95 patients underwent pulmonary CT angiography. PE was detected in 13.6% (3/22) of patients in Group A and 20.7% (6/29) in Group B. No significant differences were observed between patients with and without PE concerning hospitalization (Group B: 100% (6/6) vs. 91.3% (21/23)), the necessity of oxygen therapy (Group B: 66% (4/6) vs. 43.5% (10/23)), and death (Group B: 33% (2/6) vs. 4.3% (1/23) p > 0.05, respectively). Conclusions: In 20.7% of COVID-19 patients, PE was detected upon admission to the ED. Although the incorporation of early pulmonary CT angiography in patients suspicious of COVID-19 may be beneficial to identify concomitant PE, further studies are necessary to corroborate these findings.
Collapse
Affiliation(s)
- Benedikt M. Schaarschmidt
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany; (Y.L.); (J.H.); (J.G.); (M.F.); (L.U.)
- Correspondence: ; Tel.: +49-201-723-84168
| | - David Fistera
- Center for Emergency Medicine, Universitätsmedizin Essen, 45147 Essen, Germany; (D.F.); (C.H.)
| | - Yan Li
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany; (Y.L.); (J.H.); (J.G.); (M.F.); (L.U.)
| | - Margarete Konik
- Department of Infectious Diseases, West German Centre of Infectious Diseases, Universitätsmedizin Essen, 45147 Essen, Germany; (M.K.); (O.W.)
| | - Johannes Haubold
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany; (Y.L.); (J.H.); (J.G.); (M.F.); (L.U.)
| | - Johannes Grueneisen
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany; (Y.L.); (J.H.); (J.G.); (M.F.); (L.U.)
| | - Oliver Witzke
- Department of Infectious Diseases, West German Centre of Infectious Diseases, Universitätsmedizin Essen, 45147 Essen, Germany; (M.K.); (O.W.)
| | - Michael Forsting
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany; (Y.L.); (J.H.); (J.G.); (M.F.); (L.U.)
| | - Carola Holzner
- Center for Emergency Medicine, Universitätsmedizin Essen, 45147 Essen, Germany; (D.F.); (C.H.)
| | - Lale Umutlu
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany; (Y.L.); (J.H.); (J.G.); (M.F.); (L.U.)
| |
Collapse
|
4
|
Quarato CMI, Mirijello A, Maggi MM, Borelli C, Russo R, Lacedonia D, Foschino Barbaro MP, Scioscia G, Tondo P, Rea G, Simeone A, Feragalli B, Massa V, Greco A, De Cosmo S, Sperandeo M. Lung Ultrasound in the Diagnosis of COVID-19 Pneumonia: Not Always and Not Only What Is COVID-19 "Glitters". Front Med (Lausanne) 2021; 8:707602. [PMID: 34350201 PMCID: PMC8328224 DOI: 10.3389/fmed.2021.707602] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Accepted: 06/15/2021] [Indexed: 12/21/2022] Open
Abstract
Background: In the current coronavirus disease-2019 (COVID-19) pandemic, lung ultrasound (LUS) has been extensively employed to evaluate lung involvement and proposed as a useful screening tool for early diagnosis in the emergency department (ED), prehospitalization triage, and treatment monitoring of COVID-19 pneumonia. However, the actual effectiveness of LUS in characterizing lung involvement in COVID-19 is still unclear. Our aim was to evaluate LUS diagnostic performance in assessing or ruling out COVID-19 pneumonia when compared with chest CT (gold standard) in a population of SARS-CoV-2-infected patients. Methods: A total of 260 consecutive RT-PCR confirmed SARS-CoV-2-infected patients were included in the study. All the patients underwent both chest CT scan and concurrent LUS at admission, within the first 6-12 h of hospital stay. Results: Chest CT scan was considered positive when showing a "typical" or "indeterminate" pattern for COVID-19, according to the RSNA classification system. Disease prevalence for COVID-19 pneumonia was 90.77%. LUS demonstrated a sensitivity of 56.78% in detecting lung alteration. The concordance rate for the assessment of abnormalities by both methods increased in the case of peripheral distribution and middle-lower lung location of lesions and in cases of more severe lung involvement. A total of nine patients had a "false-positive" LUS examination. Alternative diagnosis included chronic heart disease (six cases), bronchiectasis (two cases), and subpleural emphysema (one case). LUS specificity was 62.50%. Collateral findings indicative of overlapping conditions at chest CT were recorded also in patients with COVID-19 pneumonia and appeared distributed with increasing frequency passing from the group with mild disease (17 cases) to that with severe disease (40 cases). Conclusions: LUS does not seem to be an adequate tool for screening purposes in the ED, due to the risk of missing some lesions and/or to underestimate the actual extent of the disease. Furthermore, the not specificity of LUS implies the possibility to erroneously classify pre-existing or overlapping conditions as COVID-19 pneumonia. It seems more safe to integrate a positive LUS examination with clinical, epidemiological, laboratory, and radiologic findings to suggest a "virosis." Viral testing confirmation is always required.
Collapse
Affiliation(s)
- Carla Maria Irene Quarato
- Institute of Respiratory Diseases, COVID-19 Center, Policlinico Universitario "Riuniti" di Foggia, Foggia, Italy.,Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Antonio Mirijello
- Department of Internal Medicine, COVID-19 Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Casa Sollievo della Sofferenza, Foggia, Italy
| | - Michele Maria Maggi
- Department of Emergency Medicine and Critical Care, Emergency Medicine Unit, COVID-19 Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Casa Sollievo Della Sofferenza, Foggia, Italy
| | - Cristina Borelli
- Department of Radiology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, Foggia, Italy
| | - Raffaele Russo
- Department of Emergency Medicine and Critical Care, Intensive Care Unit, COVID-19 Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Casa Sollievo Della Sofferenza, Foggia, Italy
| | - Donato Lacedonia
- Institute of Respiratory Diseases, COVID-19 Center, Policlinico Universitario "Riuniti" di Foggia, Foggia, Italy.,Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Maria Pia Foschino Barbaro
- Institute of Respiratory Diseases, COVID-19 Center, Policlinico Universitario "Riuniti" di Foggia, Foggia, Italy.,Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Giulia Scioscia
- Institute of Respiratory Diseases, COVID-19 Center, Policlinico Universitario "Riuniti" di Foggia, Foggia, Italy.,Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Pasquale Tondo
- Institute of Respiratory Diseases, COVID-19 Center, Policlinico Universitario "Riuniti" di Foggia, Foggia, Italy.,Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Gaetano Rea
- Department of Radiology, "Vincenzo Monaldi" Hospital-Association of periOperative Registered Nurses (AORN) Ospedale Dei Colli, Naples, Italy
| | - Annalisa Simeone
- Department of Radiology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, Foggia, Italy
| | - Beatrice Feragalli
- Department of Medical, Oral and Biotechnological Sciences - Radiology Unit "G. D'Annunzio, " University of Chieti-Pescara, Chieti, Italy
| | - Valentina Massa
- Department of Medical Sciences, Geriatric and COVID-19 Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Casa Sollievo della Sofferenza, Foggia, Italy
| | - Antonio Greco
- Department of Medical Sciences, Geriatric and COVID-19 Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Casa Sollievo della Sofferenza, Foggia, Italy
| | - Salvatore De Cosmo
- Department of Internal Medicine, COVID-19 Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Casa Sollievo della Sofferenza, Foggia, Italy
| | - Marco Sperandeo
- Department of Medical Sciences, Unit of Interventional and Diagnostic Ultrasound of Internal Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Casa Sollievo della Sofferenza, Foggia, Italy.,Diagnostic and Interventional Lung Ultrasonology at the Bachelor in Medicine and Surgery and the Postgraduate School of Respiratory Disease, University of Foggia, Foggia, Italy
| |
Collapse
|
5
|
Fortarezza F, Boscolo A, Pezzuto F, Lunardi F, Jesús Acosta M, Giraudo C, Del Vecchio C, Sella N, Tiberio I, Godi I, Cattelan A, Vedovelli L, Gregori D, Vettor R, Viale P, Navalesi P, Calabrese F. Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure. Mycoses 2021; 64:1223-1229. [PMID: 34157166 PMCID: PMC8446949 DOI: 10.1111/myc.13342] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Revised: 06/09/2021] [Accepted: 06/19/2021] [Indexed: 12/15/2022]
Abstract
BACKGROUND An increasing number of reports have described the COVID-19-associated pulmonary aspergillosis (CAPA) as being a further contributing factor to mortality. Based on a recent consensus statement supported by international medical mycology societies, it has been proposed to define CAPA as possible, probable, or proven on the basis of sample validity and thus diagnostic certainty. Considering current challenges associated with proven diagnoses, there is pressing need to study the epidemiology of proven CAPA. METHODS We report the incidence of histologically diagnosed CAPA in a series of 45 consecutive COVID-19 laboratory-confirmed autopsies, performed at Padova University Hospital during the first and second wave of the pandemic. Clinical data, laboratory data and radiological features were also collected for each case. RESULTS Proven CAPA was detected in 9 (20%) cases, mainly in the second wave of the pandemic (7/17 vs. 2/28 of the first wave). The population of CAPA patients consisted of seven males and two females, with a median age of 74 years. Seven patients were admitted to the intensive care unit. All patients had at least two comorbidities, and concomitant lung diseases were detected in three cases. CONCLUSION We found a high frequency of proven CAPA among patients with severe COVID-19 thus confirming at least in part the alarming epidemiological data of this important complication recently reported as probable CAPA.
Collapse
Affiliation(s)
- Francesco Fortarezza
- Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, Pathology Unit, University of Padova Medical School, Padova, Italy
| | - Annalisa Boscolo
- UOC Institute of Anaesthesia and Intensive Care Unit, Padova University Hospital, Padova, Italy
| | - Federica Pezzuto
- Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, Pathology Unit, University of Padova Medical School, Padova, Italy
| | - Francesca Lunardi
- Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, Pathology Unit, University of Padova Medical School, Padova, Italy
| | - Manuel Jesús Acosta
- Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, Pathology Unit, University of Padova Medical School, Padova, Italy
| | - Chiara Giraudo
- Department of Medicine, University of Padova Medical School, Padova, Italy
| | - Claudia Del Vecchio
- Department of Molecular Medicine, University of Padova Medical School, Padova, Italy
| | - Nicolò Sella
- Department of Medicine, University of Padova Medical School, Padova, Italy
| | - Ivo Tiberio
- Department of Urgency and Emergency, University of Padova Medical School, Padova, Italy
| | - Ilaria Godi
- Department of Urgency and Emergency, University of Padova Medical School, Padova, Italy
| | | | - Luca Vedovelli
- Department of Cardiac, Thoracic, and Public Health, Biostatistics Unit, University of Padova Medical School, Padova, Italy
| | - Dario Gregori
- Department of Cardiac, Thoracic, and Public Health, Biostatistics Unit, University of Padova Medical School, Padova, Italy
| | - Roberto Vettor
- Department of Medicine, University of Padova Medical School, Padova, Italy
| | - Pierluigi Viale
- Department of Medical and Surgical Sciences, University of Bologna - Infectious Diseases Unit - IRCCS Policlinico Sant'Orsola, Bologna, Italy
| | - Paolo Navalesi
- UOC Institute of Anaesthesia and Intensive Care Unit, Padova University Hospital, Padova, Italy.,Department of Medicine, University of Padova Medical School, Padova, Italy
| | - Fiorella Calabrese
- Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, Pathology Unit, University of Padova Medical School, Padova, Italy
| |
Collapse
|